Cited by 79MicroRNA in disease regulationBlood Coagulation and Thrombosis MechanismsBlood properties and coagulation

Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor

Open access
Witkowski, Marco, Weithauser, Alice, Tabaraie, Termeh, Steffens, Daniel, Kränkel, Nicolle, Witkowski, Mario, Stratmann, Bernd, Tschoepe, Diethelm +2 more·2016·Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective—: Diabetes mellitus involves vascular inflammatory processes and is a main contributor to cardiovascular mortality. Notably, heightened levels of circulating tissue factor (TF) account for the increased thrombogenicity and put those patients at risk for thromboembolic events. Here, we sought to investigate the role of micro-RNA (miR)–driven TF expression and thrombogenicity in diabetes mellitus. Approach and Results—: Plasma samples of patients with diabetes mellitus were analyzed for TF protein and activity as well as miR-126 expression before and after optimization of the antidiabetic treatment. We found low miR-126 levels to be associated with markedly increased TF protein and TF-mediated thrombogenicity. Reduced miR-126 expression was accompanied by increased vascular inflammation as evident from the levels of vascular adhesion molecule-1 and fibrinogen, as well as leukocyte counts. With optimization of the antidiabetic treatment miR-126 levels increased and thrombogenicity was reduced. Using a luciferase reporter system, we demonstrated miR-126 to directly bind to the F3 -3′-untranslated region, thereby reducing TF expression both on mRNA and on protein levels in human microvascular endothelial cells as well as TF mRNA and activity in monocytes. Conclusions—: Circulating miR-126 exhibits antithrombotic properties via regulating post-transcriptional TF expression, thereby impacting the hemostatic balance of the vasculature in diabetes mellitus.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/atvbaha.115.306094

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vascular tissue factor promotes thrombosis and vascular inflammation, particularly in patients with type 2 diabetes who have higher levels of circulating trimethylamine N-oxide.

    “Vascular TF promotes thrombosis and vascular inflammation123, particularl y in patients with type 2 diabetes who have higher levels of circulating TMAO124–126.”

    From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [125]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Witkowski, M., Weithauser, A., Tabaraie, T., Steffens, D., Kränkel, N., Witkowski, M., Stratmann, B., Tschoepe, D., Landmesser, U., & Rauch-Kroehnert, U.
Affiliations
  • Johannes Gutenberg University Mainz (DE)
  • From the Charité Centrum 11, Department of Cardiology, Charité–Universitätsmedizin, Berlin, Germany; Research Centre Immunology and Institute of Medical Microbiology and Hygiene, University of Mainz Medical Centre, Mainz, Germany; and Heart and Diabetes Center NRW, Ruhr University of Bochum, Bad Oeynhausen, Germany.
  • Heart and Diabetes Center North Rhine-Westphalia (DE)
Corresponding author
Rauch-Kroehnert, Ursula
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2016-06
Volume
36
Issue
6
Pages
1263-1271
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2344258676
Cited by
79
References
43
Citations by year
2025: 4 · 2024: 2 · 2023: 14 · 2022: 10 · 2021: 11 · 2020: 14 · 2019: 2 · 2018: 8 · 2017: 10 · 2016: 4
FWCI
3.34
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Blood properties and coagulation
Keywords
miR-126, tissue factor, diabetes mellitus, thrombogenicity, microRNA regulation, post-transcriptional regulation, vascular inflammation, diabetes treatment, endothelial cells, monocytes, hemostasis, fibrinogen
MeSH terms
Aged, Binding Sites, Cell Line, Diabetes Mellitus, Female, Fibrinogen, Gene Expression Regulation, Hemostasis, Humans, Hypoglycemic Agents, Male, Middle Aged, Monocytes, Thromboplastin, Thrombosis, Time Factors, Transfection, Genes, Reporter, Vascular Cell Adhesion Molecule-1, 3' Untranslated Regions, RNA Interference, MicroRNAs, Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review